PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Aug-2024 Xtant Medical Announces Closing of $5.0 Million Private Placement AccessWire
09-Aug-2024 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024 Nxera Pharma
09-Aug-2024 Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, for the Treatment of Patients with Moderate to Severe Osteoarthritis Levicept
09-Aug-2024 Valneva Scotland Receives Prestigious Award for Health and Safety Excellence Valneva
09-Aug-2024 Subsidiaries of Vita 34 reach agreement with US licensor Vita 34 AG
09-Aug-2024 Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024 AccessWire
09-Aug-2024 Lantern Pharma Announces Positive Clinical Update from Ongoing Phase 2 HARMONICâ„¢ Clinical Trial for Never Smokers with Advanced NSCLC, Including an 86% Clinical Benefit Rate in the Initial Patient Cohort Lantern Pharma
09-Aug-2024 MedEvolve Rated Top Revenue Cycle Management Workflow Optimization and Automation Solution, 2024 Black Book RCM Client Survey AccessWire
09-Aug-2024 FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team AccessWire
09-Aug-2024 Next Health Celebrates Eight Years of Pioneering Proactive Healthcare, Commits to Continued Innovation and Growth AccessWire
09-Aug-2024 Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024 Eckert & Ziegler SE
09-Aug-2024 APONTIS PHARMA with profitable revenue growth for Single Pill combinations in the first half of 2024 – forecast for the full year confirmed APONTIS PHARMA AG
09-Aug-2024 STRATEC POSTS RESULTS FOR FIRST HALF OF 2024 STRATEC SE
08-Aug-2024 StrideCare Center of Excellence Opens in Denison, Offering Comprehensive Vascular, Podiatry and Wound Care AccessWire
08-Aug-2024 Conference call on the results for the 3rd quarter 2023/24 (ending 30 June 2024) on 14 August 2024 Douglas AG
08-Aug-2024 Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024 AccessWire
08-Aug-2024 Lifeloc Reports Second Quarter 2024 Results AccessWire
08-Aug-2024 Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results AccessWire
08-Aug-2024 Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results AccessWire
08-Aug-2024 BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen AccessWire